Clinical study - Sein Adjuvant

MEDEA
Sein Adjuvant
Ouvert depuis le: 09.19.2021
Site: Paris
Public cible
Adulte
Motivating to Exercise and Diet, and Educating to healthy behaviors After breast cancer (MEDEA).
Description de l'essai

Motivating to Exercise and Diet, and Educating to healthy behaviors After BC (MEDEA) is a pragmatic randomized controlled trial (RCT) focused on obese and overweight (Body mass index [BMI]¡Ý25 Kg/m2) adult patients recruited after their initial BC treatment that aims to: 1) understand the impact of a personalized telephone-based motivational, exercise and diet intervention aimed at weight loss on the QoL of French overweight and obese BC patients. The primary aim of the study will be the impact of such personalized weight loss strategy on post-treatment fatigue. In addition, MEDEA will 2) test the feasibility of such intervention in France and 3) evaluate its overall costs and cost-effectiveness